Clover Health Investments, Corp. (CLOV)
Clover Health Investments, Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Clover Health Investments, Corp. (CLOV) is a Medical - Healthcare Plans company based in US with a market capitalization of $2.5B. Revenue grew 40.3% year-over-year and free cash flow was negative at -$69M. This page tracks CLOV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 570 employees · IPO Jun 12, 2020
Valuation
Valuation & price
$3.47as of May 17, 2026· -35.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
8.04
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.5B
Market cap
40.3%
Revenue growth (YoY)
18.5%
Gross margin
-$69M
Free cash flow (USD)
-$95.3M
Net debt
Net cash position
5.5%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2018 → 2025
Free cash flow by year
2018 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
17
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider sellJul 20, 2026Filing
Insider Sell $233K · 10b5-1 PlanSoares Karen · Chief Legal Officer · $233.2K
- Insider sellJul 17, 2026Filing
Insider Sell $22K · 10b5-1 PlanReynoso Jamie L. · CEO, Medicare Advantage · $21.9K
- 8-K eventJul 17, 2026Filing
Cybersecurity Incident
- Insider sellJul 16, 2026Filing
Insider Sell $113KWai Conrad · CEO, Counterpart Health · $113.1K
- Insider sellJul 16, 2026Filing
Insider Sell $293KToy Andrew · Director, Chief Executive Officer · $292.9K
- Insider sellJul 16, 2026Filing
Insider Sell $49KSoares Karen · Chief Legal Officer · $49.1K
- Insider sellJul 16, 2026Filing
Insider Sell $61KReynoso Jamie L. · CEO, Medicare Advantage · $61.3K
- Insider sellJul 9, 2026Filing
Insider Sell $11K · 10b5-1 PlanReynoso Jamie L. · CEO, Medicare Advantage · $11.2K
- Insider sellJul 6, 2026Filing
Insider Sell $33KReynoso Jamie L. · CEO, Medicare Advantage · $32.8K
- Insider sellJul 1, 2026Filing
Insider Sell $1.7MToy Andrew · Director, Chief Executive Officer · $1.7M
Questions
Frequently asked questions
What is Clover Health Investments, Corp.'s market cap?
Clover Health Investments, Corp. (CLOV) has a market capitalization of $2.5B.
What is CLOV's P/E ratio?
A meaningful P/E ratio is not available for CLOV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is CLOV's price-to-book (P/B) ratio?
CLOV trades at 8.04 times book value per share.
Are insiders buying CLOV stock?
SEC Form 4 filings show no open-market insider buys at Clover Health Investments, Corp. in the last 90 days (17 sells).
Same arena
Related companies in Medical - Healthcare Plans
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.